In our previous study, gene expression profiling and functional validation demonstrated that UNC13B was significantly upregulated in arsenic trioxide (ATO)-resistant K-562 chronic myeloid leukemia (CML) cells and that it promoted resistance by enhancing cell survival and suppressing apoptosis [25]. This evidence concerns the gene UNC13B and chronic myelogenous leukemia, BCR-ABL1 positive.